Agios Pharmaceuticals (AGIO)
(Real Time Quote from BATS)
$41.53 USD
+0.97 (2.39%)
Updated Oct 4, 2024 12:48 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Agios Pharmaceuticals (AGIO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$53.83 | $57.00 | $46.00 | 32.72% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Agios Pharmaceuticals comes to $53.83. The forecasts range from a low of $46.00 to a high of $57.00. The average price target represents an increase of 32.72% from the last closing price of $40.56.
Analyst Price Targets (6 )
Broker Rating
Agios Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.88 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.63 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 12.5% of all recommendations. A month ago, Strong Buy made up 62.5%, while Buy represented 12.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.88 | 1.88 | 1.63 | 1.63 | 1.63 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/27/2024 | SVB Securities | Andrew Berens | Strong Buy | Hold |
9/20/2024 | Cantor Fitzgerald & Co | Eric Schmidt | Strong Buy | Strong Buy |
9/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/1/2024 | Piper Sandler | Christopher Raymond | Strong Buy | Strong Buy |
5/3/2024 | Goldman Sachs | Salveen Richter | Hold | Hold |
4/1/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.88 |
ABR (Last week) | 1.88 |
# of Recs in ABR | 8 |
Average Target Price | $53.83 |
LT Growth Rate | 13.20% |
Industry | Medical - Products |
Industry Rank by ABR | 49 of 252 |
Current Quarter EPS Est: | 0.05 |
AGIO FAQs
Agios Pharmaceuticals, Inc. (AGIO) currently has an average brokerage recommendation (ABR) of 1.88 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for Agios Pharmaceuticals, Inc. (AGIO) is $53.83. The current on short-term price targets is based on 4 reports.
The forecasts for Agios Pharmaceuticals, Inc. (AGIO) range from a low of $46 to a high of $57. The average price target represents a increase of $32.72 from the last closing price of $40.56.
The current UPSIDE for Agios Pharmaceuticals, Inc. (AGIO) is 32.72%
Based on short-term price targets offered by six analysts, the average price target for Agios Pharmaceuticals comes to $53.83. The forecasts range from a low of $46.00 to a high of $57.00. The average price target represents an increase of 32.72% from the last closing price of $40.56.